PLENADREN Trademark

Trademark Overview

On Tuesday, November 23, 2010, a trademark application was filed for PLENADREN with the United States Patent and Trademark Office. The USPTO has given the PLENADREN trademark a serial number of 79090742. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, November 24, 2020. This trademark is owned by DuoCort Pharma AB. The PLENADREN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations containing glucocorticoids for oral administration
plenadren

General Information

Serial Number79090742
Word MarkPLENADREN
Filing DateTuesday, November 23, 2010
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, November 24, 2020
Registration Number3983727
Registration DateTuesday, June 28, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 12, 2011

Trademark Statements

Goods and ServicesPharmaceutical preparations containing glucocorticoids for oral administration

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, February 2, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDuoCort Pharma AB
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSE
Party NameDuoCort Pharma AB
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSE
Party NameDuoCort Pharma AB
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSE

Trademark Events

Event DateEvent Description
Saturday, June 12, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Saturday, June 12, 2021DEATH OF INTERNATIONAL REGISTRATION
Friday, November 13, 2020NEW REPRESENTATIVE AT IB RECEIVED
Thursday, June 4, 2020NEW REPRESENTATIVE AT IB RECEIVED
Saturday, December 15, 2018TOTAL INVALIDATION PROCESSED BY THE IB
Wednesday, October 10, 2018TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Wednesday, October 10, 2018INVALIDATION PROCESSED
Tuesday, October 2, 2018TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, February 2, 2018CANCELLED SECTION 71
Thursday, May 4, 2017NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, June 28, 2016COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, June 19, 2015NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, March 17, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, March 17, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, December 18, 2011NOTIFICATION PROCESSED BY IB
Thursday, September 22, 2011FINAL DISPOSITION NOTICE SENT TO IB
Thursday, September 22, 2011FINAL DISPOSITION PROCESSED
Thursday, July 28, 2011GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, June 28, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, April 12, 2011PUBLISHED FOR OPPOSITION
Thursday, March 24, 2011NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, March 24, 2011NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 23, 2011NOTICE OF PUBLICATION
Thursday, March 3, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 3, 2011ASSIGNED TO EXAMINER
Saturday, January 8, 2011APPLICATION FILING RECEIPT MAILED
Tuesday, January 4, 2011NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, December 30, 2010SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

plenadren oral administration glucocorticoids containing preparations pharmaceutical